phase readout
saveNCT03831932: Telaglenastat Hydrochloride and Osimertinib in Treating Patients With EGFR-Mutated Stage IV Non-small Cell Lung Cancer
ACTIVE_NOT_RECRUITINGupdated 2d ago
community read0 votes
Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
view source ↗
comments(0)
5-min edit window · permanent after that